How to Buy Praxis Precision Medicines Stock
Praxis Precision Medicines Inc
Praxis Precision Medicines, Inc. , a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance.
Praxis Precision Medicines stock last closed at $37.64, up 1.18% from the previous day, and has decreased 31.4% in one year. It has overperformed other stocks in the Biotechnology industry by 0.45 percentage points. Praxis Precision Medicines stock is currently +40.97% from its 52-week low of $26.70, and -59.01% from its 52-week high of $91.83.
As of Apr 30, 2025, there are 20.16M PRAX shares outstanding. The market value of PRAX is $758.94M. In the last 24 hours, 588,430 PRAX shares were traded.
How to Buy Praxis Precision Medicines Stock
Not sure how to invest in Praxis Precision Medicines stock? Here's how.
- Figure out where to buy Praxis Precision Medicines stock: You need to choose a stock brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you determine where to buy Praxis Precision Medicines stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit funds into your investment account: Pick your method of payment and add your info.
- Research Praxis Precision Medicines stock: The Praxis Precision Medicines ticker symbol is PRAX. Is Praxis Precision Medicines stock a good investment? Should you buy shares of PRAX? How do PRAX's underlying business fundamentals look? Do top analysts think Praxis Precision Medicines is a good buy? Why has PRAX's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if PRAX is a good stock to buy).
- Place your PRAX purchase: Decide if you will purchase PRAX shares at the current market price or use a limit order to buy PRAX stock at a specific price.
- Keep tabs on your PRAX investment: Create a watchlist to watch your investment in Praxis Precision Medicines shares.
Step 1: Figure out where to buy Praxis Precision Medicines stock
You need a brokerage account in order to access the NASDAQ market and buy PRAX shares.
Our favorite brokerage: eToro
In our opinion, eToro is the best online stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to global financial markets: From Technology to Healthcare, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've chosen the best brokerage, you'll need to fill out some personal details so you are able to buy PRAX stock today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to start a new brokerage account.
- Submit your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you've filled out your info on a good stock buying app, you can securely and quickly fund your account:
Check out the tutorial below if you need help transferring funds into your new brokerage account.
Step 4: Research Praxis Precision Medicines stock
After you have selected the best place to buy Praxis Precision Medicines stock, it's critical to evaluate their stock prior to investing, so you actually understand the risk as well as the upside.
Praxis Precision Medicines Numbers
PRAX Due Diligence Checks
WallStreetZen was created to help part-time investors perform better fundamental analysis quickly.
You can view all of the due diligence checks on PRAX's stock page.
Is PRAX stock undervalued?
Analysts use many financial metrics, analyses, models, and charts to gauge PRAX's intrinsic value.
Using relative valuations measures:
- PRAX may be undervalued based on its P/B ratio of 1.7x, relative to Biotechnology industry P/B ratio of 4.45x
You can do more valuation research on PRAX's stock here.
PRAX Financials at a glance
Positive Financial Indicators:
- PRAX has cash burn of 131757000. It has enough cash and short-term investments to cover this for at least one year.
- Total PRAX debt is lower than 5 years ago, relative to shareholder equity.
- PRAX has $392.57M in cash and short term investments. This is sufficient to cover its annual cash burn of $131.76M.
- PRAX has a low debt to equity ratio of 0.09.
- There are more short-term assets than long-term liabilities on the PRAX balance sheet.
- There are more short-term assets than short-term liabilities on the PRAX balance sheet.
Negative Financial Indicators:
- PRAX profit margin has gone up by 29 percentage points in the past year, but the company is still unprofitable.
Is it a good time to buy Praxis Precision Medicines stock, according to Wall Street analysts?
Out of 5 sell side analysts who give ratings on PRAX, the consensus analyst rating on Praxis Precision Medicines is a Strong Buy
Please note that analyst forecasts are not recommendations, nor are they investment advice.
You can dig deeper into what analysts are saying on the Praxis Precision Medicines stock forecast page.
PRAX Technicals
PRAX Performance Metrics
Last year, PRAX revenue was $8.55M. During the past one years, PRAX's revenue has grown by 249.53% per year. This was faster than the Biotechnology industry average of 45.66%.
Dig into PRAX's earnings and revenue performance here.
Are PRAX insiders buying or selling the stock?
In the last 12 months, insiders at PRAX have sold more shares than they have bought.
Lauren Mastrocola, Principal Accounting Officer of PRAX, was the latest PRAX insider to sell. They sold $3,416.00 worth of PRAX stock on Feb 12, 2025.
Dig into more about who owns PRAX shares here.
Can I get consistent income from PRAX stock?
No, Praxis Precision Medicines doesn't provide an income stream by paying out dividends.
Get opinions from other traders
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Place your PRAX purchase
There are two primary order types:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are usually sufficient. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a given dollar amount, use a limit order.
Hit the Open button and eToro will execute your order.
If you want additional assistance buying stocks on eToro, watch the helpful video below:
Step 6: Keep tabs on your PRAX investment
Now that you own some PRAX stock, you'll want to keep up with your new investment.
Create a watchlist to monitor your PRAX stock.
PRAX Feed
How to Buy Stock in Praxis Precision Medicines
To reiterate, here are the 6 steps for buying Praxis Precision Medicines stock:
- Figure out where to buy Praxis Precision Medicines stock
- Create a brokerage account
- Deposit funds into your investment account
- Research Praxis Precision Medicines stock
- Place your PRAX purchase
- Keep tabs on your PRAX investment
If you are looking for a online brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to keep tabs on your investment in Praxis Precision Medicines, create a watchlist today.
Trending Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.